Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
Clinical trial NCT02910999 · COMPLETED
Trial details
- NCT number
- NCT02910999
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-08-09
- Primary completion
- 2023-12-31
- Enrollment
- 868
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.